{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:43:14Z","timestamp":1785681794634,"version":"3.56.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1309\/ajcpk1ov6imnpfgl","type":"journal-article","created":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T15:19:07Z","timestamp":1405091947000},"page":"173-183","source":"Crossref","is-referenced-by-count":26,"title":["Evaluation of Contemporary Prostate and Urothelial Lineage Biomarkers in a Consecutive Cohort of Poorly Differentiated Bladder Neck Carcinomas"],"prefix":"10.1093","volume":"142","author":[{"given":"Sambit K.","family":"Mohanty","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Luthringer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen M.","family":"Gown","sequence":"additional","affiliation":[{"name":"PhenoPath Laboratories, Seattle, WA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Aron","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahul B.","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"key\n\t\t\t\t20180602033125_b1-1420173","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0022-5347(17)35302-8","article-title":"Prostate specific antigen and Gleason grade: an immunohistochemical study of prostate cancer","volume":"151","author":"Aihara","year":"1994","journal-title":"J Urol"},{"key":"key\n\t\t\t\t20180602033125_b2-1420173","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1309\/G6PR-Y774-X738-FG2K","article-title":"Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores","volume":"117","author":"Goldstein","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b3-1420173","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.semdp.2005.11.001","article-title":"Immunohistochemistry in diagnostic surgical pathology of the prostate","volume":"22","author":"Hameed","year":"2005","journal-title":"Semin Diagn Pathol"},{"key":"key\n\t\t\t\t20180602033125_b4-1420173","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0344-0338(96)80226-3","article-title":"Immunohistochemical labelling for prostate specific antigen in non-prostatic tissues","volume":"192","author":"Alanen","year":"1996","journal-title":"Pathol Res Pract"},{"key":"key\n\t\t\t\t20180602033125_b5-1420173","first-page":"xiv","volume-title":"AJCC Cancer Staging Manual","author":"Edge","year":"2010","edition":"7th ed"},{"key":"key\n\t\t\t\t20180602033125_b6-1420173","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.6004\/jnccn.2012.0114","article-title":"Prostate cancer, version 3.2012: featured updates to the NCCN guidelines","volume":"10","author":"Mohler","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"key\n\t\t\t\t20180602033125_b7-1420173","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.humpath.2012.05.018","article-title":"Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract","volume":"44","author":"Gulmann","year":"2013","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602033125_b8-1420173","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/01.pas.0000213438.01278.5f","article-title":"Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray","volume":"31","author":"Higgins","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602033125_b9-1420173","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1053\/hupa.2002.129416","article-title":"Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma","volume":"33","author":"Mhawech","year":"2002","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602033125_b10-1420173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602033125_b11-1420173","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.prp.2005.11.007","article-title":"Analysis of NKX3.1 expression in prostate cancer tissues and correlation with clinicopathologic features","volume":"202","author":"Aslan","year":"2006","journal-title":"Pathol Res Pract"},{"key":"key\n\t\t\t\t20180602033125_b12-1420173","first-page":"6111","article-title":"Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression","volume":"60","author":"Bowen","year":"2000","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180602033125_b13-1420173","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/PAS.0b013e31802f5d33","article-title":"Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma","volume":"31","author":"Chuang","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602033125_b14-1420173","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1746-1596-6-67","article-title":"Diagnostic utility of p63\/P501S double sequential immunohistochemical staining in differentiating urothelial carcinoma from prostate carcinoma","volume":"6","author":"Srinivasan","year":"2011","journal-title":"Diagn Pathol"},{"key":"key\n\t\t\t\t20180602033125_b15-1420173","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","article-title":"A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers","volume":"26","author":"Camp","year":"2008","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602033125_b16-1420173","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1200\/JCO.2012.45.3662","article-title":"Advancing precision medicine for prostate cancer through genomics","volume":"31","author":"Roychowdhury","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180602033125_b17-1420173","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1309\/AJCPCGFDF4ECG8QN","article-title":"Immunohistochemistry cocktails are here to stay: Center for Medicare and Medicaid Services should revise its new reimbursement policy","volume":"138","author":"Yaziji","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b18-1420173","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.humpath.2012.12.012","article-title":"Use of PAX8 and GATA3 in diagnosing sarcomatoid renal cell carcinoma and sarcomatoid urothelial carcinoma","volume":"44","author":"Chang","year":"2013","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602033125_b19-1420173","first-page":"3051","article-title":"Expression of S100 protein family members in the pathogenesis of bladder tumors","volume":"27","author":"Yao","year":"2007","journal-title":"Anticancer Res"},{"issue":"12","key":"key\n\t\t\t\t20180602033125_b20-1420173","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1097\/PAS.0b013e31829e2525","article-title":"Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas","volume":"37","author":"Zhao","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602033125_b21-1420173","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.humpath.2012.11.003","article-title":"GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas","volume":"44","author":"Cimino-Mathews","year":"2013","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602033125_b22-1420173","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b23-1420173","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA3: A multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors","volume":"38","author":"Miettinen","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602033125_b24-1420173","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/modpathol.2013.76","article-title":"GATA3 expression in paragangliomas: a pitfall potentially leading to misdiagnosis of urothelial carcinoma","volume":"26","author":"So","year":"2013","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20180602033125_b25-1420173","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e318260cde7","article-title":"Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t20180602033125_b26-1420173","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/his.12360","article-title":"Uroplakin II outperforms uroplakin III in diagnostically challenging settings","volume":"65","author":"Smith","year":"2014","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20180602033125_b27-1420173","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.humpath.2012.08.004","article-title":"Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecules","volume":"44","author":"Gandou","year":"2013","journal-title":"Hum Pathol"},{"key":"key\n\t\t\t\t20180602033125_b28-1420173","doi-asserted-by":"crossref","first-page":"601","DOI":"10.5858\/arpa.2011-0326-OA","article-title":"Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas","volume":"136","author":"Liu","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20180602033125_b29-1420173","doi-asserted-by":"crossref","first-page":"e65501","DOI":"10.1371\/journal.pone.0065501","article-title":"S100P expression is a novel prognostic factor in hepatocellular carcinoma and predicts survival in patients with high tumor stage or early recurrent tumors","volume":"8","author":"Yuan","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180602033125_b30-1420173","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1309\/V1RY91NKX5ARW2Q5","article-title":"Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and\/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma","volume":"125","author":"Kunju","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b31-1420173","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/modpathol.3880175","article-title":"Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases","volume":"13","author":"Chu","year":"2000","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20180602033125_b32-1420173","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2559.2005.02188.x","article-title":"Diagnostic utility of immunohistochemistry in morphologically difficult prostate cancer: review of current literature","volume":"47","author":"Varma","year":"2005","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20180602033125_b33-1420173","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jcp.2003.014894","article-title":"Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining","volume":"57","author":"Varma","year":"2004","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b34-1420173","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1309\/BGWQ-P26T-7TR6-VGT3","article-title":"Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology","volume":"118","author":"Varma","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b35-1420173","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1158\/0008-5472.CAN-04-2442","article-title":"Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program","volume":"64","author":"Shah","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20180602033125_b36-1420173","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2559.2007.02635.x","article-title":"Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using multiple tumour tissue microarray technique","volume":"50","author":"Mhawech-Fauceglia","year":"2007","journal-title":"Histopathology"},{"key":"key\n\t\t\t\t20180602033125_b37-1420173","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.urolonc.2009.01.033","article-title":"Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression","volume":"29","author":"Tuygun","year":"2011","journal-title":"Urol Oncol"},{"key":"key\n\t\t\t\t20180602033125_b38-1420173","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/jclinpath-2013-201586","article-title":"Diagnostic utility of androgen receptor expression in discriminating poorly differentiated urothelial and prostate carcinoma","volume":"66","author":"Downes","year":"2013","journal-title":"J Clin Pathol"},{"key":"key\n\t\t\t\t20180602033125_b39-1420173","doi-asserted-by":"crossref","first-page":"935","DOI":"10.5858\/arpa.2011-0424-OA","article-title":"Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies","volume":"136","author":"Tomlins","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"key\n\t\t\t\t20180602033125_b40-1420173","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/modpathol.2012.234","article-title":"Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma","volume":"26","author":"Bhalla","year":"2013","journal-title":"Mod Pathol"},{"key":"key\n\t\t\t\t20180602033125_b41-1420173","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t20180602033125_b42-1420173","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1593\/neo.10726","article-title":"Antibody-based detection of ERG rearrangement-positive prostate cancer","volume":"12","author":"Park","year":"2010","journal-title":"Neoplasia"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/142\/2\/173\/24998074\/ajcpath142-0173.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,12]],"date-time":"2019-08-12T14:55:11Z","timestamp":1565621711000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/142\/2\/173\/1766403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcpk1ov6imnpfgl","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,8,1]]},"published":{"date-parts":[[2014,8,1]]}}}